Fibroblast Growth Factor-23 (FGF-23) ELISA

BioMarkers | Diabetic Nephropathy | Inflammation


The K-ASSAY®Human fibroblast growth factor-23 (FGF-23) ELISA is an enzyme-linked immunosorbent assay for the quantitative determination of human FGF23 in serum, plasma, cell culture supernatant, body fluid and tissue homogenate.

FGF family members possess broad mitogenic and cell survival activities relevant to biological processes, such as cell growth and tissue repair. FGF23 works as a hormone to regulate phosphorus and vitamin D metabolism. Specifically, FGF23 reduces serum phosphate level by suppressing phosphate reabsorption in the renal proximal tubules and phosphate absorption in the intestine.

Elevated FGF23 levels are associated with cardiovascular and chronic kidney diseases (CKD).



Species reactivity


Sample type

Serum, plasma, cell culture supernatant, body fluid and tissue homogenate

Assay type



1.0 pg/mL

Detection method


Assay time

1h 30min

Request Quote/More Information

Check also our collection of ANIMAL FGF-23 ELISA Kits


Partner: Kamiya BioMedical Company

FGF-23 ELISA - Product Insert | "Research Use Only"

BioMarkers | Diabetic Nephropathy | Inflammation

BioMarkers | Diabetic Nephropathy | Oxidative Stress

BioMarkers | Diabetic Nephropathy | Fibrosis

BioMarkers | Diabetic Nephropathy | Injury and Dysfunction

Diabetic Nephropathy - BioMarker Overview

Download the BioMarker Overview Table here, including detailed information about 28 suggested biomarker assays.

Request Quote / Request More Information
Are You Working with CRISPRs, ZFNs or TALENs?

Genome Editing Tools and Services:

  • 100 % Gene Expression Control using the TUNR Flexible Gene Editing System.
  • Create your own Disease Zebrafish Model powered by ZeClinics
  • Optimize your Detection of Insertions and Deletions (INDELS) using the IDAA Method.

Read more in our Genome Editing Resources section.